ArticleOpen medicine (Warsaw, Poland)2026
Diagnostic efficacy of monocyte distribution width to high-sensitivity C-reactive protein ratio in differentiating pathogen types in community-acquired pneumonia: a retrospective cohort study.
Article in Open medicine (Warsaw, Poland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Community-acquired pneumonia (CAP) remains a diagnostic challenge in emergency departments, where rapid and accurate pathogen differentiation is essential for appropriate antimicrobial therapy and stewardship. Current biomarkers demonstrate limited accuracy in distinguishing bacterial from viral and atypical pathogens, necessitating novel diagnostic approaches. This study aimed to assess the diagnostic accuracy of the monocyte distribution width to high-sensitivity C-reactive protein ratio (MDW/hs-CRP) for differentiating bacterial, viral, atypical, and mixed community-acquired pneumonia (CAP) pathogens. Methods: This retrospective cohort study enrolled 486 adult patients with radiologically confirmed CAP in an emergency department (Jan 2023-Dec 2024). Pathogens were identified using comprehensive microbiological testing. MDW was measured via automated hematology analyzer (Beckman Coulter DxH900); hs-CRP via standard assays. The primary outcome compared the MDW/hs-CRP ratio's diagnostic accuracy to individual biomarkers using ROC analysis (DeLong test), Youden index (cutoff), decision curve analysis (DCA), and subgroup analyses. Results: Pathogen distribution: 198 (40.7 %) bacterial, 142 (29.2 %) viral, 89 (18.3 %) atypical, 57 (11.7 %) mixed. For distinguishing bacterial from viral CAP, the MDW/hs-CRP ratio significantly outperformed MDW alone (AUC 0.752) and hs-CRP alone (AUC 0.798), achieving an AUC of 0.893 (95 % CI: 0.865-0.921; p<0.001). The optimal cutoff (0.185) yielded 85.4 % sensitivity and 82.7 % specificity. Performance remained consistent in subgroups. DCA showed clinical utility across threshold probabilities (15-65 % net benefit). Conclusions: The MDW/hs-CRP ratio shows promise as a rapid tool for pathogen differentiation in CAP, potentially aiding early antimicrobial decisions in emergency care. Multicenter validation is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.